Trial · NCT01218971
Adverse events264
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 264
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Medisorb Naltrexone 380mg--Combined | 16 | 175 | |
| other | Nasopharyngitis | Infections and infestations | Medisorb Naltrexone 190mg--Combined | 21 | 157 | |
| other | Nasopharyngitis | Infections and infestations | Placebo to 380mg | 8 | 60 | |
| other | Nasopharyngitis | Infections and infestations | 380mg to 380mg | 8 | 115 | |
| other | Nasopharyngitis | Infections and infestations | Placebo to 190mg | 6 | 55 | |
| other | Nasopharyngitis | Infections and infestations | 190mg to 190mg | 15 | 102 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | Medisorb Naltrexone 380mg--Combined | 18 | 175 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | Medisorb Naltrexone 190mg--Combined | 18 | 157 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | Placebo to 380mg | 6 | 60 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | 380mg to 380mg | 12 | 115 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | Placebo to 190mg | 7 | 55 | |
| other | Upper respiratory tract infection NOS | Infections and infestations | 190mg to 190mg | 11 | 102 | |
| other | Sinusitis NOS | Infections and infestations | Medisorb Naltrexone 380mg--Combined | 7 | 175 | |
| other | Sinusitis NOS | Infections and infestations | Medisorb Naltrexone 190mg--Combined | 9 | 157 | |
| other | Sinusitis NOS | Infections and infestations | Placebo to 380mg | 5 | 60 | |
| other | Sinusitis NOS | Infections and infestations | 380mg to 380mg | 2 | 115 | |
| other | Sinusitis NOS | Infections and infestations | Placebo to 190mg | 4 | 55 | |
| other | Sinusitis NOS | Infections and infestations | 190mg to 190mg | 5 | 102 | |
| other | Influenza | Infections and infestations | Medisorb Naltrexone 380mg--Combined | 11 | 175 | |
| other | Influenza | Infections and infestations | Medisorb Naltrexone 190mg--Combined | 1 | 157 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01218971/events